Insider · CIK 0001625184
Aharon Schwartz
Files at PLX (Protalix BioTherapeutics, Inc.). First filing Aug 12, 2025, latest Aug 12, 2025.
Aharon Schwartz files SEC Form 4 as director at PLX (Protalix BioTherapeutics, Inc.). Since Aug 12, 2025, Aharon Schwartz has reported 1 open-market buy worth $206k and 0 open-market sells worth $0, the latest filed on Aug 12, 2025.
A track record needs three past buys with six months of prices behind them; Aharon Schwartz has 0, so none is measured yet.
The newest scored trade: bought $206k of PLX on Jun 10, 2025, filed Aug 12, 2025, scored 37 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PLX: Protalix BioTherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | PLXbuy Protalix BioTherapeutics, Inc. | $206k 129,000 shares | +74% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +17,000 | $0.00 | $0 | 17,000 | 34 d ago |
| Sep 3, 2026 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +8,500 | $0.00 | $0 | 8,500 | 34 d ago |
| Sep 3, 2025 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Common Stockindirect: By Trust | +7,500 | - | - | 7,500 | Sep 4, 2025 |
| Sep 3, 2025 | PLX Protalix BioTherapeutics, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +15,000 | $0.00 | $0 | 15,000 | Sep 4, 2025 |
| Jun 10, 2025 | PLX Protalix BioTherapeutics, Inc. | POpen-market purchase Common Stock | +129,000 | $1.60 | $206k | 303,000 | Aug 12, 2025 |
Questions about Aharon Schwartz
Answered from the filings on this page, as of the latest one.
Is Aharon Schwartz buying or selling?
Not in the last 12 months. Aharon Schwartz's latest open-market trade on SEC Form 4 was bought $206k of PLX on Jun 10, 2025.
How did Aharon Schwartz's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Aharon Schwartz has 0.
Where does Aharon Schwartz file Form 4?
Aharon Schwartz has filed Form 4 at PLX (Protalix BioTherapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.